Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A layered standards framework for integrating single-cell and spatial omics data into brain cell atlases.

bioRxiv : the preprint server for biology·2026
Same author

A Community Standard Multispecies Cell Atlas of the Basal Ganglia.

bioRxiv : the preprint server for biology·2026
Same author

Pilot randomised controlled trial of a novel form of exercise on parkinsonism symptoms.

BMJ neurology open·2026
Same author

Widening access to penicillin allergy assessment in the United Kingdom-a proposed implementation plan for the National Health Service (NHS).

JAC-antimicrobial resistance·2026
Same author

The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis.

BMJ open·2025
Same author

Integrative analysis of genomic and transcriptomic data informs precancer progression in the pancreas.

bioRxiv : the preprint server for biology·2025
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Multiple sclerosis: Cognition and saccadic eye movements.

Joanne Fielding1, Trevor Kilpatrick, Lynette Millist

  • 1Centre for Neuroscience, University of Melbourne, Parkville, Victoria, Australia. fij@unimelb.edu.au

Journal of the Neurological Sciences
|November 4, 2008
PubMed
Summary
This summary is machine-generated.

Eye movement analysis reveals cognitive deficits in Multiple Sclerosis (MS) patients, offering a new way to track disease progression. This research highlights ocular motor measures as sensitive indicators of cognitive function in MS.

More Related Videos

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

VisualEyes: A Modular Software System for Oculomotor Experimentation
10:41

VisualEyes: A Modular Software System for Oculomotor Experimentation

Published on: March 25, 2011

Related Experiment Videos

Last Updated: Jun 28, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

VisualEyes: A Modular Software System for Oculomotor Experimentation
10:41

VisualEyes: A Modular Software System for Oculomotor Experimentation

Published on: March 25, 2011

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Neurology

Background:

  • Ocular motor abnormalities are common in Multiple Sclerosis (MS).
  • The Expanded Disability Status Scale (EDSS) inadequately represents cognitive function in MS.
  • Eye movement analysis may offer a complementary measure for cognitive assessment in MS.

Purpose of the Study:

  • To investigate ocular motor function in individuals with MS.
  • To correlate eye movement measures with cognitive performance in MS patients.
  • To explore the potential of ocular motor measures as surrogate markers for MS severity.

Main Methods:

  • Studied single and triple-step memory-guided saccades in 25 MS patients and 25 healthy controls.
  • Correlated ocular motor measures with neuropsychological tests assessing attention, working memory, and executive functions.
  • Matched participants for age and IQ.

Main Results:

  • MS patients showed reduced accuracy and increased errors in single memory-guided saccades.
  • MS patients exhibited prolonged saccadic latencies for single-step tasks.
  • MS patients demonstrated less accuracy and greater variability in triple-step memory-guided saccades.
  • Significant correlations were found between ocular motor measures and cognitive test scores, particularly for working memory and inhibitory control.

Conclusions:

  • Ocular motor measures are sensitive indicators of cognitive dysfunction in MS.
  • Eye movement analysis can complement traditional scales like EDSS for assessing MS.
  • Ocular motor measures show promise as user-friendly surrogate markers for MS disease severity and progression.